USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Terumo Kabushiki Kaisha

USPTO PatentsView assignee record - 1,250 granted patents across 112 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

1,250

Total patents granted

112

CPC technology areas

14.7

Avg claims per patent

+16%

5-year filing velocity

The verdict

Terumo holds 1,250 US patents across 112 technology areas, rank #342 of 50,000 tracked assignees.

#342
of 50,000 US assignees by volume: Top 2%
by Innovation Score (63.4/100): 14.7
avg claims per patent: +16%
filing velocity, last 5 yrs

Portfolio overview

Terumo Kabushiki Kaisha has been granted 1,250 US utility patents between 2015 and 2025, placing Terumo Kabushiki Kaisha at rank #342 across all assignees tracked by PlainPatent. This portfolio spans 112 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.7 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Terumo Kabushiki Kaisha is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Terumo sits between Nippon Steel Corporation (1,289 patents, rank #338) and Symantec Corporation (1,244 patents, rank #346) - the closest US assignees by grant volume. The composite Innovation Score of 63.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 671 grants, compared with 579 in the 2015–2019 window, a +16% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Terumo Kabushiki Kaisha's 14.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Terumo Kabushiki Kaisha against peers pursuing similar technology classes.

Nippon Steel

1,289
SZ DJI Technology

1,268
Edwards Lifescien…

1,265
The Trustees of t…

1,264
Terumo ◀

1,250
Empire Technology…

1,248
Merck Sharp & Doh…

1,248
Synopsys

1,245
Symantec

1,244

What this shows Terumo holds 1,250 patents at rank #342, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Terumo

By rank, the assignees closest to #342 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Terumo's primary technology class.

Terumo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

63 Top 2% higher than 98% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Terumo Kabushiki Kaisha patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	80	6.4%
2016	84	6.7%
2017	102	8.2%
2018	135	10.8%
2019	178	14.2%
2020	138	11.0%
2021	122	9.8%
2022	129	10.3%
2023	111	8.9%
2024	87	7.0%
2025	84	6.7%

Which technologies does Terumo Kabushiki Kaisha patent most?

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 724

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 488

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 153

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 126

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 65

A61J - CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 50

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 44

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 44

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 41

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 35

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 35

B29L - INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES 33

B01D - SEPARATION 33

C08F - MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 30

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 29

Top 15 of 112 technology areas

Patent Moat Analysis

Portfolio Volume Strong

Tech Breadth Diversified

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#342

Across all tracked assignees

Innovation Score

63.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Terumo Kabushiki Kaisha hold?

Terumo Kabushiki Kaisha holds 1,250 US granted patents filed between 2015 and 2025, spanning 112 technology areas.

What is Terumo Kabushiki Kaisha's Innovation Score?

Terumo Kabushiki Kaisha has an Innovation Score of 63.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Terumo Kabushiki Kaisha focus on?

Terumo Kabushiki Kaisha's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 724 patents. The company has filed patents in 112 CPC subclasses total.

Is Terumo Kabushiki Kaisha's patent filing rate increasing or decreasing?

Terumo Kabushiki Kaisha's recent filing velocity is +16% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Terumo Kabushiki Kaisha's patents?

Terumo Kabushiki Kaisha's patents average 14.7 claims each. This falls within the standard range, providing solid legal coverage.

How is the Terumo Kabushiki Kaisha patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Terumo's 1,250 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Terumo ranks #342 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.